par Laurent, Sébastien;Monsaert, Els;Boterberg, Tom;Demols, Anne
;Borbath, Ivan;Polus, Marc;Hendlisz, Alain
;de Hemptinne, Bernard;Mahin, C;Scalliet, Pierre;Van Laethem, Jean-Luc
;Peeters, Michel 
Référence Annals of oncology, 20, 8, page (1369-1374)
Publication Publié, 2009-08




Référence Annals of oncology, 20, 8, page (1369-1374)
Publication Publié, 2009-08
Article révisé par les pairs
Titre: |
|
Auteur: | Laurent, Sébastien; Monsaert, Els; Boterberg, Tom; Demols, Anne; Borbath, Ivan; Polus, Marc; Hendlisz, Alain; de Hemptinne, Bernard; Mahin, C; Scalliet, Pierre; Van Laethem, Jean-Luc; Peeters, Michel |
Informations sur la publication: | Annals of oncology, 20, 8, page (1369-1374) |
Statut de publication: | Publié, 2009-08 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Chemotherapy |
Cholangio carcinoma | |
Gemcitabine | |
Oxaliplatin | |
Pancreatic cancer | |
Radiotherapy | |
MeSH keywords: | Adenocarcinoma -- drug therapy -- radiotherapy |
Adult | |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects -- therapeutic use | |
Cholangiocarcinoma -- drug therapy -- radiotherapy -- surgery | |
Combined Modality Therapy | |
Deoxycytidine -- administration & dosage -- adverse effects -- analogs & derivatives | |
Dose-Response Relationship, Drug | |
Feasibility Studies | |
Female | |
Humans | |
Male | |
Middle Aged | |
Organoplatinum Compounds -- administration & dosage -- adverse effects | |
Pancreatic Neoplasms -- drug therapy -- radiotherapy -- surgery | |
Prospective Studies | |
Treatment Outcome | |
Note générale: | Clinical Trial, Phase I |
Clinical Trial, Phase II | |
Journal Article | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0923-7534 |
info:doi/10.1093/annonc/mdp005 | |
info:pii/mdp005 | |
info:scp/69449098070 | |
info:pmid/19457936 |